SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 5 filers reported holding SEATTLE GENETICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,581,379 | +51.6% | 21,595 | +37.6% | 0.04% | +80.0% |
| Q2 2023 | $3,021,430 | +964.8% | 15,699 | +611.0% | 0.02% | +1150.0% |
| Q4 2022 | $283,750 | -84.4% | 2,208 | -78.5% | 0.00% | -88.2% |
| Q2 2022 | $1,815,000 | +136.9% | 10,257 | +93.0% | 0.02% | +183.3% |
| Q1 2022 | $766,000 | +23.7% | 5,315 | +32.8% | 0.01% | +100.0% |
| Q4 2021 | $619,000 | -49.2% | 4,001 | -44.2% | 0.00% | -62.5% |
| Q3 2021 | $1,218,000 | -74.3% | 7,171 | -76.1% | 0.01% | -75.8% |
| Q2 2021 | $4,731,000 | +391.3% | 29,966 | +332.3% | 0.03% | +450.0% |
| Q1 2021 | $963,000 | -65.9% | 6,932 | -57.0% | 0.01% | -57.1% |
| Q4 2020 | $2,823,000 | +49.0% | 16,119 | +66.6% | 0.01% | -22.2% |
| Q3 2020 | $1,894,000 | -0.4% | 9,678 | -13.6% | 0.02% | -10.0% |
| Q2 2020 | $1,902,000 | +16.4% | 11,196 | -21.0% | 0.02% | -4.8% |
| Q1 2020 | $1,634,000 | +7.2% | 14,165 | +6.2% | 0.02% | +110.0% |
| Q4 2019 | $1,524,000 | – | 13,337 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 57,170 | $10,013,000 | 5.39% |
| Boxer Capital, LLC | 400,000 | $70,056,000 | 2.25% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 110,153 | $19,292,000 | 1.10% |
| DCF Advisers, LLC | 13,300 | $2,329,000 | 0.96% |
| XTX MARKETS LLC | 2,418 | $423,000 | 0.87% |
| FAIRFIELD, BUSH & CO. | 15,035 | $2,633,000 | 0.77% |
| Parcion Private Wealth LLC | 4,520 | $792,000 | 0.10% |
| Gulf International Bank (UK) Ltd | 26,091 | $4,569,000 | 0.06% |
| Princeton Portfolio Strategies Group LLC | 1,500 | $263,000 | 0.05% |
| Redpoint Investment Management Pty Ltd | 2,392 | $419,000 | 0.04% |